<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04526483</url>
  </required_header>
  <id_info>
    <org_study_id>LG-4K, 3D &amp; ICG</org_study_id>
    <nct_id>NCT04526483</nct_id>
  </id_info>
  <brief_title>L-Gastrectomy With the Intelligent Navigation 4K UHD 3D Endoscopic Imaging System</brief_title>
  <official_title>Safety and Efficacy of a Novel Intelligent Navigation 4K UHD 3D Endoscopic Imaging System in Laparoscopic Gastrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Minimally Invasive Surgery Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Minimally Invasive Surgery Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the safety, efficacy, and feasibility of the Intelligent&#xD;
      Navigation 4K UHD 3D Endoscopic Imaging System in patients with gastric cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Lymphadenectomy in laparoscopic gastrectomy can significantly improve the&#xD;
      long-term survival and accuracy of the tumor staging of patients with gastric cancer. The&#xD;
      retrieval of more lymph nodes has gradually become a trend among surgeons. However,&#xD;
      lymphadenectomy is currently performed without the aid of visual instruments which might lead&#xD;
      to an unknown pathological outcome and influence the prognosis of gastric cancer patients.&#xD;
      And none of the indocyanine green (ICG) fluorescent imaging systems applied in clinical&#xD;
      practice now is equipped with ultra-high definition (4K) or three-dimensional (3D) lens. To&#xD;
      explore the advent of minimally invasive surgery with a conveniently switchable high-quality&#xD;
      imaging system, we designed a new laparoscopic navigating technique that combined all the&#xD;
      three characteristics.&#xD;
&#xD;
      Aims: This study aims to evaluate the safety, efficacy, and feasibility of the Intelligent&#xD;
      Navigation 4K UHD 3D Endoscopic Imaging System in patients with gastric cancer.&#xD;
&#xD;
      Methods/design This is a prospective, one-arm, single-center, single-set target value&#xD;
      clinical trial to investigate the clinical value of the Intelligent Navigation 4K UHD 3D&#xD;
      Endoscopic Imaging System on laparoscopic gastric surgery. The trial will recruit a total of&#xD;
      67 participants.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This is a prospective, one-arm, single-center, single-set target value clinical trial to investigate the clinical value of the Intelligent Navigation 4K UHD 3D Endoscopic Imaging System on laparoscopic gastric surgery. The trial will recruit a total of 67 participants.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The success rate of laparoscopic gastric surgery</measure>
    <time_frame>24 months</time_frame>
    <description>Rate of successfully performed laparoscopic gastrectomy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lymph node dissection rate</measure>
    <time_frame>24 months</time_frame>
    <description>The numbers of lymph node dissected in the surgery</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">67</enrollment>
  <condition>Stomach Neoplasms</condition>
  <arm_group>
    <arm_group_label>laparoscopic gastrectomy with Intelligent Navigation 4K UHD 3D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laparoscopic gastrectomy with Intelligent Navigation 4K UHD 3D Endoscopic Imaging System</intervention_name>
    <description>Laparoscopic gastrectomy with Intelligent Navigation 4K UHD 3D Endoscopic Imaging System</description>
    <arm_group_label>laparoscopic gastrectomy with Intelligent Navigation 4K UHD 3D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Diagnosed with gastric cancer require surgery;&#xD;
&#xD;
          2. Without a history of abdominal surgery;&#xD;
&#xD;
          3. BMI â‰¤ 30 kg/m2;&#xD;
&#xD;
          4. Preoperative ECOG score is 0~1 and ASA score is I~III;&#xD;
&#xD;
          5. Having signed the Medical Informed Consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with metastasis or invasion of surrounding tissues;&#xD;
&#xD;
          2. Undergoing emergency operation (perforation, hemorrhage, obstruction);&#xD;
&#xD;
          3. Patients with serious medical co-morbidity (heart, lung, liver and kidney diseases)&#xD;
             and could not tolerate laparoscopic surgery;&#xD;
&#xD;
          4. With poor incorrigible physical condition before surgery;&#xD;
&#xD;
          5. The patient who underwent gastrojejunostomy or jejunostomy;&#xD;
&#xD;
          6. The patient who refuses to accept standardized postoperative systemic therapy&#xD;
             according to the guidelines.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Junjun Ma</last_name>
    <phone>13917283686</phone>
    <email>zmhtiger@yeah.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Minhua Zheng</last_name>
  </overall_contact_backup>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 19, 2020</study_first_submitted>
  <study_first_submitted_qc>August 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2020</study_first_posted>
  <last_update_submitted>August 21, 2020</last_update_submitted>
  <last_update_submitted_qc>August 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Laparoscopy</keyword>
  <keyword>Gastrectomy</keyword>
  <keyword>4K</keyword>
  <keyword>3D</keyword>
  <keyword>lymphadenectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

